Search

everythinglearnresearchcommunity

for

Search:↓

Upadacitinib successfully regrew hair in a child with alopecia universalis and specific genetic mutations.

Six genetic conditions are often linked to complete scalp hair loss in children.

A girl with a rare genetic condition affecting hair and nails also developed a common type of hair loss, suggesting a possible genetic link.

A young man's hair loss was the only sign of syphilis, which improved after treatment.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Minoxidil can cause a skin reaction called ALEP.

Vitiligo and alopecia areata may have similar causes despite their differences.

The guideline provides recommendations for managing alopecia areata effectively.

Early intervention in patch-type alopecia may prevent progression to more severe forms by targeting immune pathways and preserving keratin.

The conclusion is that genetic testing is important for diagnosing and treating various genetic hair disorders.

Curly hair is mechanically different from straight hair and may need new testing methods.

Giant axonal neuropathy changes the structure of keratin in human hair.

A man with X-ALD improved after treatment, highlighting the need to consider X-ALD in similar patients and test their relatives.

Genetic testing confirmed a rare skin disorder in a young girl, which improved with zinc supplementation.

The text talks about a rare skin condition causing hair loss and suggests that people with this should also check their lung and heart health.

The Hedgehog Signaling Pathway is important for skin and hair development and skin cancer treatment, but more research is needed to understand it fully.

Oral testosterone therapy raises heart risk more than other methods.

Both mouse and rat models are effective for testing alopecia areata treatments.

Researchers created a skin patch that delivers two drugs for treating enlarged prostate, which may improve patient use and dosage control.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

Dermal papilla microtissues could be useful for initial hair growth drug testing.

Advanced human skin models improve drug development and could replace animal testing.

Light can turn on hair growth cells through a nerve path starting in the eyes.

Some skin lymphomas can look like common skin issues and need careful testing to diagnose correctly.

Bimatoprost is promising for treating some types of hair loss but needs more testing for androgenetic alopecia.

The created skin model with melanoblasts improves the study of skin color and offers an alternative to animal testing.

Allergic reactions to blood thinners are rare but can be serious, requiring careful testing and alternative treatments.

Testosterone causes hair loss in AGA mice, which are good for testing baldness treatments, and both minoxidil and cyproterone acetate can prevent this hair loss.

Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.